Comparison of gadofosveset trisodium and gadobenate dimeglumine during time-resolved thoracic MR angiography at 3T.

Standard

Comparison of gadofosveset trisodium and gadobenate dimeglumine during time-resolved thoracic MR angiography at 3T. / Frydrychowicz, Alex; Russe, Maximilian F; Bock, Jelena; Stalder, Aurélien F; Bley, Thorsten; Harloff, Andreas; Markl, Michael.

in: ACAD RADIOL, Jahrgang 17, Nr. 11, 11, 2010, S. 1394-1400.

Publikationen: SCORING: Beitrag in Fachzeitschrift/ZeitungSCORING: ZeitschriftenaufsatzForschungBegutachtung

Harvard

Frydrychowicz, A, Russe, MF, Bock, J, Stalder, AF, Bley, T, Harloff, A & Markl, M 2010, 'Comparison of gadofosveset trisodium and gadobenate dimeglumine during time-resolved thoracic MR angiography at 3T.', ACAD RADIOL, Jg. 17, Nr. 11, 11, S. 1394-1400. <http://www.ncbi.nlm.nih.gov/pubmed/20650665?dopt=Citation>

APA

Frydrychowicz, A., Russe, M. F., Bock, J., Stalder, A. F., Bley, T., Harloff, A., & Markl, M. (2010). Comparison of gadofosveset trisodium and gadobenate dimeglumine during time-resolved thoracic MR angiography at 3T. ACAD RADIOL, 17(11), 1394-1400. [11]. http://www.ncbi.nlm.nih.gov/pubmed/20650665?dopt=Citation

Vancouver

Frydrychowicz A, Russe MF, Bock J, Stalder AF, Bley T, Harloff A et al. Comparison of gadofosveset trisodium and gadobenate dimeglumine during time-resolved thoracic MR angiography at 3T. ACAD RADIOL. 2010;17(11):1394-1400. 11.

Bibtex

@article{7a2eb41eb712482a8ccef295f3f5d475,
title = "Comparison of gadofosveset trisodium and gadobenate dimeglumine during time-resolved thoracic MR angiography at 3T.",
abstract = "Gadofosveset trisodium is a blood-pool contrast agent (BPA) that shows a less pronounced r1 relaxivity advantage over gadobenate dimeglumine at 3T than at 1.5T. However, there are few data on image quality during first-pass imaging of the thoracic vasculature with gadofosveset trisodium at 3 T. Therefore, it was the aim of this study to compare first-pass imaging characteristics of gadofosveset trisodium to gadobenate dimeglumine during time-resolved contrast-enhanced three-dimensional magnetic resonance angiography (CE MRA) at 3 T.",
author = "Alex Frydrychowicz and Russe, {Maximilian F} and Jelena Bock and Stalder, {Aur{\'e}lien F} and Thorsten Bley and Andreas Harloff and Michael Markl",
year = "2010",
language = "Deutsch",
volume = "17",
pages = "1394--1400",
journal = "ACAD RADIOL",
issn = "1076-6332",
publisher = "Elsevier USA",
number = "11",

}

RIS

TY - JOUR

T1 - Comparison of gadofosveset trisodium and gadobenate dimeglumine during time-resolved thoracic MR angiography at 3T.

AU - Frydrychowicz, Alex

AU - Russe, Maximilian F

AU - Bock, Jelena

AU - Stalder, Aurélien F

AU - Bley, Thorsten

AU - Harloff, Andreas

AU - Markl, Michael

PY - 2010

Y1 - 2010

N2 - Gadofosveset trisodium is a blood-pool contrast agent (BPA) that shows a less pronounced r1 relaxivity advantage over gadobenate dimeglumine at 3T than at 1.5T. However, there are few data on image quality during first-pass imaging of the thoracic vasculature with gadofosveset trisodium at 3 T. Therefore, it was the aim of this study to compare first-pass imaging characteristics of gadofosveset trisodium to gadobenate dimeglumine during time-resolved contrast-enhanced three-dimensional magnetic resonance angiography (CE MRA) at 3 T.

AB - Gadofosveset trisodium is a blood-pool contrast agent (BPA) that shows a less pronounced r1 relaxivity advantage over gadobenate dimeglumine at 3T than at 1.5T. However, there are few data on image quality during first-pass imaging of the thoracic vasculature with gadofosveset trisodium at 3 T. Therefore, it was the aim of this study to compare first-pass imaging characteristics of gadofosveset trisodium to gadobenate dimeglumine during time-resolved contrast-enhanced three-dimensional magnetic resonance angiography (CE MRA) at 3 T.

M3 - SCORING: Zeitschriftenaufsatz

VL - 17

SP - 1394

EP - 1400

JO - ACAD RADIOL

JF - ACAD RADIOL

SN - 1076-6332

IS - 11

M1 - 11

ER -